Aqualaurin

Aqualaurin by Northstar Biosciences is a water soluble form of monolaurin and the ultimate biofilm disruptor. It is great to use for viruses, mold, candida and other infections.

In 2010, Northstar Biosciences (NBI) developed and patented a water-soluble version of glycerol monolaurate (WS-GML) with selected ‘phytochemicals’ under the trademark of AquaLaurin. Our therapeutic nanotechnology is based on bi-continuous, self assembled, lipid vesicles which form unique nanoemulsions and nanocapsules.

Key Advantages: Increase energy Supports immune system Promotes a blanced biome key features & benefits of AquaLaurin (AL) besides killing pathogenic bacteria & deactivating enveloped viruses?

· Prevention & disruption of chronic inflammatory pathogenic biofilms · Effective immunomodulator reducing autoimmune response · Effective anti-inflammatory including suppression of pro-inflammatory chemokines & cytokines & prostaglandins · No pathogenic microbial resistance with prolonged AL usage observed · AL does not harm good gut bacteria balance in GI tract · AL enhances uptake & bioavailability of nutrients, vitamins & minerals · AL works in conjunction with the body’s innate immune system · Tick Borne Disease (TBD) protocols can be ‘customized’ to minimize Herxheimer reactions

This information is partially comprised of excerpts borrowed from over a dozen research papers and university findings funded by the NIH.

References available upon request.

See Product Label.

Additional Notes These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. CAUTION: As the pateint's biofilm load begins to dissipate in the ciruculatory system and/or gastrointestinal tract, any pre-existing medicateions being taken for Blood Thinner's, High Blood Pressure, High Choleterol, Type 1 & 2 Diabetes will have to be monitored and in most cases, will need to be reduced or possibly eliminated. Note: AL will be processed within the body's biome by 72 hours from last dosage.

Variant 1